mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |